Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery

Summary

Study designed to evaluate the safety and efficacy of double staining with brilliant blue G 0.025% as an adjuvant to macular surgery. Patients undergoing surgery for macular hole or epiretinal membrane will be included. Safety will be evaluated by optic coherence tomography, pattern reversal electroretinogram and multifocal electroretinogram.

Timeline

Start

2013-01

Primary completion

2014-02

Completion

2014-02

Outcome

Outcome not reported

Stopped: “Undefined”

Drugs

Indications